Skip to content

EMDR vs. TF-CBT after Stabilisation in the treatment of posttraumatic stress disorder following type II trauma

EMDR vs. TF-CBT after Stabilisation in the treatment of posttraumatic stress disorder following type II trauma - EMDR vs. TF-CBT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34998
Enrollment
90
Registered
2010-09-17
Start date
2010-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

posttraumatic stress disorder

Interventions

In both conditions, participants will first receive 8 sessions of stabilization treatment according to the STAIR protocol (Cloitre, Cohen, & Koenen, 2006). In the second phase, participants will eit
see Cloitre et al., 2006) or 16 sessions of EMDR (Shapiro, 1995).

Sponsors

Universiteit van Amsterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Meeting DSM-IV criteria for PTSD 2) having experienced repeated or chronic interpersonal trauma before the age of 14 (e.g., sexual or physical abuse) 3) at least 18 years of age 4) having sufficient fluency in Dutch to complete treatment and research protocol 5) Participants using prescribed anti-depressant medication are required to be on a stable dose for at least 2 weeks before the beginning of treatment and remain on this dose throughout the treatment.

Exclusion criteria

Exclusion criteria: 1) Psychiatric problems that may interfere with the study participation or that require more intensive care than can be offered in the present study, including dementia, psychotic symptoms, depression with suicidal ideation, full-blown borderline personality disorder, substance dependence 2) current use of tranquilizers

Design outcomes

Primary

MeasureTime frame
The main dependent variables are (1) the percentage of participants meeting DSM-IV criteria for PTSD according to the Structured Clinical Interview for the DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1996) (2) the PTSD symptom severity, assessed with the Clinian-administered PTSD Scale (CAPS; Blake et al., 1995) and the Posttraumatic Diagnostic Scale (PDS; Foa, Cashman, Jaycox, & Perry, 1997).

Secondary

MeasureTime frame
Secondary study parameters are: (1) Symptom levels/clinical problems typically associated with PTSD following early-onset chronic interpersonal trauma, namely (a) Symptom levels of depression assessed with the Beck Depression Inventory (BDI; Beck, Rush, Shaw, & Emery, 1979) (b) Levels of anger, assessed with the State Trait Anger Inventory (STAXI; Spielberger, 1991) (c) Emotion regulation difficulties, assessed with the Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004) (d) Interpersonal problems, assessed with the Inventory of Interpersonal Problems (IIP; Horowitz, Rosenberg, Baer, Ureno, & Villasenor, 1988) (e) Dissociation, assessed with the Dissociative Experiences Scale (DES; Bernstein & Putnam, 1986) (f) Quality of Life, assessed with the WHO Quality of Life Questionnaire (WHO-QoL; Trompenaars, Masthoff, Van Heck, Hodiamont, & De Vries, 2005) (2) Variables shown to be involved in the maintenance of PTSD that can be expected to be reduced as a consequence of successful treatment, namely (a) negative trauma-related appraisals, assessed with the Posttraumatic Cognitions Inventory (PTCI; van Emmerik, Schoorl, Emmelkamp, & Kamphuis, 2006) (b) dysfunctional coping strategies (e.g., avoidance, safety behaviours, rumination, thought suppression) assess with the Responses to Intrusions Questionnaire (RIQ; Ehring, Ehlers, & Glucksman, 2006) and the Avoidance and Safety Behaviours Questionnaire (ASBQ; Ehring et al., 2006) (c) characteristics of the trauma memory, assessed with the Trauma Memory Questionnaire (TMQ; Halligan, Michael, Clark, & Ehlers, 2003) and a narrative task (d) social support, assessed with the Crisis Support Scale (CSS; Joseph, 1999)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)